Neurology Minute

In part two of this two-part series, Dr. Jeff Ratliff and Dr. Harry Sutherland discuss the diverse strategies that residency programs implement to ensure residents can continue their education in a protected and supportive environment.  Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200205  

In part one of this two-part series, Dr. Jeff Ratliff and Dr. Harry Sutherland discuss how neurology residency programs are incorporating didactic teaching methods to enhance learning outside the clinical environment. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200205  

Dr. Jessica Ailani and Dr. Richard B. Lipton discuss the significance of recognizing prodromal symptoms, the findings from the PRODROME trial, and the implications for clinical practice.  Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200359  

Dr. Tesha Monteith discusses an abstract that was presented at the AAN Annual Meeting titled, "Estrogen Exposure from Modern Hormonal Contraceptives and Vascular Risk in Women with Migraine: A Nationwide Electronic Health Record Database Study." Show reference:  https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-002306.html  

In the final episode of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss the abstract she presented at the AAN Annual Meeting and details on the upcoming gene therapy trial.  Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000208987 

Prof. Jon Stone, Dr. Laura Strom, and Meagan Watson discuss functional seizures and healthcare costs related to the functional seizure program at the University of Colorado. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200393  

Neurology ® Open Access has officially launched!  In part two of this two-part series, Dr. Jeff Ratliff and Dr. Amy C. Kunchok discuss the advantages of an open-access publication model. Read the related editorial in Neurology ® Open Access .

Neurology ® Open Access has officially launched!  In part one of this two-part series, Dr. Jeff Ratliff and Dr. Amy C. Kunchok discuss the scope and focus of Neurology ® Open Access (NOA). Read the related editorial in Neurology ® Open Access .  

In part two of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss current treatment options for Leber hereditary optic neuropathy (LHON). Show reference:   https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-002206.html    

In part two of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss current treatment options for Leber hereditary optic neuropathy (LHON). Show reference:   https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-002206.html   

In part two of this two-part series, Dr. Jeff Ratliff and Dr. Mehari Gebreyohanns discuss the essence of humanistic care.   

In part one of this two-part series, Dr. Jeff Ratliff and Dr. Mehari Gebreyohanns discuss the Bahir Dar Outreach for Neurology Education (BORNE) initiative. 

Dr. Gordon Smith and Dr. Jennifer Morganroth discuss the trends in thymectomy utilization for myasthenia gravis. References:  https://www.neurology.org/doi/10.1212/CPJ.0000000000200335   

In part one of this four-part series, Dr. Justin Abbatemarco and Dr. Nancy Newman discuss how Leber hereditary optic neuropathy (LHON) typically presents and outline the steps for diagnosing LHON in a clinical setting. Show reference:  https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-002206.html  

Dr. Joyce K. Lee-Iannotti introduces the collaborative section showcase happening in-person at the 77 th AAN Annual Meeting on Monday, April 7th, from 12:00 - 1:00 pm PDT in room 24AB. Experts from the sleep, headache, and concussion sections are coming together to host a pro/con debate on pressing issues affecting the field of neurology. Click here to learn more about the AAN Section Showcase: Bu...

In the fourth and final episode of this four-part series, Dr. Justin Abbatemarco and Dr. Albert Aboseif discuss treatment options currently available for patients with LGI-1-AE. Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-003990.html  

Dr. Andrea Gropman and Dr. Stefan Pulst discuss the significant advancements in Neurology ® Genetics over the past decade. Show reference:  https://www.neurology.org/doi/10.1212/NXG.0000000000200252  

Dr. Jessica Ailani and Dr. Francesca Puledda discuss the International Headache Society's global practice recommendations for acute and preventive treatment of migraine. Show reference:  https://journals.sagepub.com/doi/10.1177/03331024241252666   https://journals.sagepub.com/doi/full/10.1177/03331024241269735  

In the third episode of this four-part series, Dr. Justin Abbatemarco and Dr. Albert Aboseif discuss the inspiration behind this abstract. Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-003990.html

In the second part of this four-part series, Dr. Justin Abbatemarco and Dr. Albert Aboseif discuss treatment options for LGI-1 encephalitis.  Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-003990.html

In part one of this four-part series, Dr. Justin Abbatemarco and Dr. Albert Aboseif discuss how LGI-1 encephalitis typically presents in clinic and how to make the correct diagnosis. Show reference: https://index.mirasmart.com/AAN2025/PDFfiles/AAN2025-003990.html  

Dr. Dan Ackerman and Dr. Phillip Ferdinand discuss the impact smoking has on stroke risk.  Show reference: https://www.neurology.org/doi/10.1212/WN9.0000000000000003  

Dr. Gordon Smith and Dr. Timothy Miller discuss compelling clinical data suggesting that ALS may be a treatable disease for a subset of patients.

In the final part of this three-part series, Dr. Jason Crowell delves into the third issue discussed at NOH, funding for NINDS and the BRAIN Initiative. Show reference: https://www.aan.com/advocacy/  

In the second part of this three-part series, Dr. Jason Crowell delves into the second issue discussed at NOH, emphasizing the importance of extending telehealth flexibilities. Show reference: https://www.aan.com/advocacy/